Racial inequities in cardiovascular health care persist in rural areas of the United States.
All articles by Gary Rothbard MD, MS
What do the new guidelines and recommendations advise regarding patient selection and the most appropriate clinical use of CAC scoring for ASCVD risk assessment?
Scientific statement by AHA detailing the current understanding of menopause transition and its impact on the risk for postmenopausal cardiovascular disease.
Low mean levels and high variability of HDL-C were found to be associated with increased risks for stroke, myocardial infarction and all-cause mortality.
Canagliflozin was not found to be inferior to glimepiride for the treatment of patients with type 2 diabetes mellitus and stable congestive heart failure.
Subcutaneous administration of inclisiran every 6 months was found to reduce low-density lipoprotein cholesterol by 50% in patients with atherosclerotic cardiovascular disease.
Cardiac injury was found to be common in patients with coronavirus disease 2019 hospitalized at a single center in Wuhan, China medical center.
The incidence of major adverse cardiac events was found to be associated with levels of lipoprotein(a) in patients with diabetes who are prescribed statin medications for coronary artery disease, following percutaneous coronary intervention.
intensive glucose-lowering therapy associated with a reduced risk for coronary heart disease in patients with type 2 diabetes with hp2-2 genotype.
Bariatric surgery in obese patients was found to be associated with decreased risks for hypertension, heart failure, and all-cause mortality compared with routine care.